Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Heart Arrest | Phase 2 | ClinicalTrials |
| Heart Failure | Phase 2 | ClinicalTrials |
| Parkinson Disease | Phase 2 | ClinicalTrials |
| Sepsis; Toxemia | Phase 2 | ClinicalTrials |
| Fatigue | Phase 3 | ClinicalTrials |
CONTENTS
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Heart Arrest | Phase 2 | ClinicalTrials |
| Heart Failure | Phase 2 | ClinicalTrials |
| Parkinson Disease | Phase 2 | ClinicalTrials |
| Sepsis; Toxemia | Phase 2 | ClinicalTrials |
| Fatigue | Phase 3 | ClinicalTrials |